4//SEC Filing
Meline David W 4
Accession 0001127602-21-005296
CIK 0001682852other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:23 PM ET
Size
11.4 KB
Accession
0001127602-21-005296
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-09+25,618→ 25,618 totalExercise: $179.52From: 2022-02-09Exp: 2031-02-09→ Common Stock (25,618 underlying) - Award
Restricted Stock Units
2021-02-09+5,570→ 5,570 totalExercise: $0.00From: 2022-02-09→ Common Stock (5,570 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001444612
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:23 PM ET
- Size
- 11.4 KB